Shock

Journal Abbreviation: SHOCK
Journal ISSN: 1073-2322

About Shock

    SHOCK®: Injury, Inflammation, and Sepsis: Laboratory and Clinical Approaches includes studies of novel therapeutic approaches, such as immunomodulation, gene therapy, nutrition, and others. The mission of the Journal is to foster and promote multidisciplinary studies, both experimental and clinical in nature, that critically examine the etiology, mechanisms and novel therapeutics of shock-related pathophysiological conditions. Its purpose is to excel as a vehicle for timely publication in the areas of basic and clinical studies of shock, trauma, sepsis, inflammation, ischemia, and related pathobiological states, with particular emphasis on the biologic mechanisms that determine the response to such injury.
Year Impact Factor (IF) Total Articles Total Cites
2022 (2023 update) 3.1 - 9054
2021 3.533 - 10085
2020 3.454 184 9489
2019 2.960 186 7919
2018 3.083 183 7638
2017 3.005 188 7437
2016 3.113 197 6828
2015 3.048 161 6552
2014 3.045 165 6536
2013 2.732 147 6465
2012 2.612 184 6161
2011 2.848 174 5993
2010 3.203 184 6124